| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0006-291X(81)91628-4 |
| P698 | PubMed publication ID | 6946774 |
| P2093 | author name string | T Suda | |
| H Tanaka | |||
| K Konno | |||
| T Kuribayashi | |||
| E Abe | |||
| Y Nishii | |||
| C Miyaura | |||
| P2860 | cites work | Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture | Q40512568 |
| P433 | issue | 3 | |
| P921 | main subject | myeloid leukemia | Q11688946 |
| P304 | page(s) | 937-943 | |
| P577 | publication date | 1981-10-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | 1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells | |
| P478 | volume | 102 |
| Q37600754 | 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells |
| Q34605470 | 1 alpha,25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor |
| Q69873272 | 1 alpha,25-dihydroxyvitamin D3 inhibits pokeweed mitogen-stimulated human B-cell activation: an analysis using serum-free culture conditions |
| Q72737731 | 1 alpha-hydroxyvitamin D3 inhibits type II collagen-induced arthritis in rats |
| Q68342389 | 1,25-Dihydroxyvitamin D3 enhancement of concanavalin-A induced bovine lymphocyte proliferation: requirement of monocytes |
| Q72698309 | 1,25-Dihydroxyvitamin D3 increases bone alkaline phosphatase isoenzyme levels in human osteogenic sarcoma cells |
| Q72392354 | 1,25-Dihydroxyvitamin D3 inhibits selectively the mitogenic stimulation of mouse medullary thymocytes |
| Q69676680 | 1,25-Dihydroxyvitamin D3, but not retinoic acid, induces the differentiation of U937 cells |
| Q36209927 | 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells |
| Q45992467 | 1,25-Dihydroxyvitamin D3-mediated inhibition of human B cell differentiation. |
| Q70161320 | 1,25-Dihydroxyvitamin D3Receptors in Human Leukocytes |
| Q36298643 | 1α,25(OH)(2)-Vitamin D3 increases dysferlin expression in vitro and in a human clinical trial. |
| Q41554261 | 1α,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60) |
| Q28322640 | 1α,25-Dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1 |
| Q67253474 | 1α,25-dihydroxyvitamin D3 suppresses proliferation of murine granulocyte-macrophage progenitor cells (CFU-C) |
| Q43124030 | A non-functioning vitamin D receptor predisposes to leukaemoid reactions in mice |
| Q77403222 | A novel aminosteroid is active for proliferation inhibition and differentiation induction of human acute myeloid leukemia HL-60 cells |
| Q72569535 | A role for 1,25-dihydroxyvitamin D3 in control of bone-marrow collagen deposition? |
| Q37808261 | A systems approach to bone pathophysiology |
| Q37288171 | Adjudication of the alleged role of vitamin d in the antimicrobial pathway |
| Q39829800 | An in vitro-differentiated human cell line as a model system to study the interaction of Neisseria gonorrhoeae with phagocytic cells |
| Q41673660 | Bufalin as a potent inducer of differentiation of human myeloid leukemia cells |
| Q39990649 | C18 ceramide analysis in mammalian cells employing reversed-phase high-performance liquid chromatography tandem mass spectrometry. |
| Q61023219 | Calcitriol and cancer therapy: A missed opportunity |
| Q61649229 | Calcitriol inhibits the PHA-induced production of IL-2 and IFN-γ and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules |
| Q83498122 | Characteristics of U-937 and HL-60 leukemia cells differentiated by spinach extract |
| Q36417543 | Clinical experience using vitamin d and analogs in the treatment of myelodysplasia and acute myeloid leukemia: a review of the literature |
| Q51925517 | Combination of automated high throughput platforms, flow cytometry, and hierarchical clustering to detect cell state. |
| Q67921420 | Cooperative effects of tumor necrosis factor-alpha and 1,25-dihydroxyvitamin D3 on growth inhibition, differentiation, and c-myc reduction in human promyelocytic leukemia cell line HL-60 |
| Q37298263 | Covalent modification of proteins by ligands of steroid hormone receptors |
| Q70170223 | Cyclic AMP-like effects of polyamines on phosphatidylcholine synthesis and protein phosphorylation in human promyelocytic leukemia HL60 cells. Comparison with the effects of phorbol ester |
| Q33822041 | Defective binding of macrophages to bone in rodent osteomalacia and vitamin D deficiency. In vitro evidence for a cellular defect and altered saccharides in the bone matrix. |
| Q67265979 | Demonstration and Characterisation of a Testicular Receptor for 1,25-Dihydroxycholecalciferol in the Rat |
| Q42507224 | Demonstration and characterization of 1,25-dihydroxyvitamin D3 receptors in basal cells of epidermis of neonatal and adult mice |
| Q68257886 | Dephosphorylation of specific proteins in HL-60 cells by 1α, 25-dihydroxyvitamin D3: Possible involvement of cAMP-dependent protein kinase |
| Q69856611 | Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men |
| Q38161360 | Differentiation therapy of acute myeloid leukemia. |
| Q33409795 | Differentiation therapy of leukemia: 3 decades of development |
| Q31431976 | Differentiation-inducing effect of magnolialide, a 1 beta-hydroxyeudesmanolide isolated from Cichorium intybus, on human leukemia cells |
| Q41155076 | Differentiation-related regulation of 1,25 dihydroxy vitamin D3receptor mRNA in human leukaemia cells HL-60 |
| Q47783344 | Down-regulation of telomerase activity is an early event of cellular differentiation without apparent telomeric DNA change |
| Q35954885 | Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance |
| Q44855831 | Effect of anti-TNF therapy and vitamin D derivatives on the proliferation of peripheral blood mononuclear cells in Crohn's disease |
| Q42437853 | Effects of 1 alpha,25-dihydroxyvitamin D3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosis |
| Q71804607 | Effects of vitamin D3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT 29 cells: possible implication of intracellular calcium |
| Q34723871 | Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells |
| Q35600481 | Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells |
| Q39829512 | Established leukemia cell lines: their role in the understanding and control of leukemia proliferation |
| Q40862202 | Etoposide stimulates 1,25-dihydroxyvitamin D3 differentiation activity, hormone binding and hormone receptor expression in HL-60 human promyelocytic cells |
| Q31950170 | Examination of structurally selective derivatization of vitamin D(3) analogues by electrospray mass spectrometry |
| Q40107544 | Fundamentals of Chemotherapy of Myeloid Leukemia by Induction of Leukemia Cell Differentiation |
| Q78024359 | Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells |
| Q42285092 | High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome |
| Q74628370 | Identification of epithelial and myeloid-specific DNA elements regulating MRP14 gene transcription |
| Q41700006 | Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation |
| Q42463232 | Impairment of cytokine production in mice fed a vitamin D3-deficient diet |
| Q67263776 | Induction by retinoic acid of NAD+-glycohydrolase activity of myelomonocytic cell lines HL-60, THP-1 and U-937, and fresh human acute promyelocytic leukemia cells in primary culture |
| Q41028236 | Induction of differentiation and apoptosis by dithizone in human myeloid leukemia cell lines |
| Q40539927 | Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones |
| Q31883540 | Induction of differentiation of human myeloid leukemia cells by novel synthetic neurotrophic pyrimidine derivatives |
| Q72612922 | Induction of macrophagic and granulocytic differentiation of murine bone marrow progenitor cells by 1,25-dihydroxyvitamin D3 |
| Q37514883 | Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. |
| Q41695203 | Induction of the differentiation of HL-60 cells by phorbol 12-myristate 13-acetate activates a Na(+)-dependent uridine-transport system. Involvement of protein kinase C. |
| Q40163964 | Influence of 1,25-(OH)2 vitamin D3 and gamma interferon on the phenotype of human peripheral blood monocyte-derived macrophages |
| Q70326660 | Influence of 1,25-hydroxyvitamin D3 on cytosolic free calcium concentrations |
| Q42205471 | Influence of vitamin D3 metabolites on the production of interleukins 1,2 and 3. |
| Q34617856 | Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol) |
| Q69676666 | Inhibition of human natural killer activity by antiserum against vitamin D-binding protein, a group-specific component (Gc) |
| Q42819464 | Inhibitory effect of 1 alpha,25-dihydroxyvitamin D3 on the growth of the renal carcinoma cell line |
| Q41601775 | Investigation of Vitamin D Receptor Gene Polymorphism in Pediatric Patients with Brain Cancer |
| Q71991569 | Isolation and characterization of new 18-membered macrolides FD-891 and FD-892 |
| Q70069529 | Joint meeting of the British Association for Cancer Research & the Royal Society of Medicine (Section of Oncology) (incorporating a symposium on "Clonal evolution of tumours"). November 22-23, 1984. Abstracts |
| Q37628136 | Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia |
| Q34206010 | MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis. |
| Q40562410 | Molecular biology of vitamin D action |
| Q37195857 | Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications |
| Q54065714 | Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs. |
| Q38166375 | Noncoding RNAs in Acute Myeloid Leukemia: From Key Regulators to Clinical Players |
| Q41148225 | Nonhypercalcemic 1,25-(OH)2D3 analogs potently induce the human osteocalcin gene promoter stably transfected into rat osteosarcoma cells (ROSCO-2) |
| Q34412330 | Optimization of growth inducing factors for colony forming and attachment of bone marrow-derived mesenchymal stem cells regarding bioengineering application. |
| Q37047500 | Peroxisome proliferation-activated receptor δ agonist GW0742 interacts weakly with multiple nuclear receptors, including the vitamin D receptor |
| Q34638729 | Perspectives in cancer chemoprevention |
| Q26991440 | Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs |
| Q70160035 | Possible significance of new target tissues for 1,25-dihydroxyvitamin D3 |
| Q28216383 | Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML |
| Q42113844 | Production of C-24- and C-23-oxidized metabolites of 1,25-dihydroxycholecalciferol by cultured kidney cells (LLC PK1) and their presence in kidney in vivo |
| Q43807135 | Prolactin-Stimulated X-linked inhibitor of apoptosis protein expression during S phase cell cycle progression in rat Nb2 lymphoma cells |
| Q40941342 | Prostaglandin E2 regulates vitamin D receptor expression, vitamin D-24-hydroxylase activity and cell proliferation in an adherent human myeloid leukemia cell line (Ad-HL60). |
| Q54695309 | Protective effect of vitamin D3 analogues on endotoxin shock in mice. |
| Q36587617 | Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns |
| Q34375661 | Regulation of metallothionein gene expression by 1 alpha,25-dihydroxyvitamin D3 in cultured cells and in mice |
| Q28609877 | Regulation of the mRNA for monocyte-derived neutrophil-activating peptide in differentiating HL60 promyelocytes |
| Q93015032 | Repurposing vitamin D for treatment of human malignancies via targeting tumor microenvironment |
| Q73248586 | Reversibility of monocytic differentiation of HL-60 cells by 1alpha,25 dihydroxyvitamin D3 |
| Q36376155 | Role of promyelocytic leukemia (PML) protein in tumor suppression |
| Q38614926 | Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis |
| Q41871277 | Stimulation of creatine kinase BB activity by 1 alpha,25-dihydroxycholecalciferol and 24R,25-dihydroxycholecalciferol in rat tissues |
| Q41727352 | Subclones of a rat parathyroid cell line (PT-r): Regulation of growth and production of parathyroid hormone-related peptide (PTHRP) |
| Q31923455 | Suppressive effect of 1,25-dihydroxyvitamin D3 and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis |
| Q40131885 | Synergistic effect of AS101 and Bryostatin-1 on myeloid leukemia cell differentiation in vitro and in an animal model |
| Q43655396 | Synergistic effects of highly unsaturated fatty acid-containing phosphatidyl-ethanolamine on differentiation of human leukemia HL-60 cells by dibutyryl cyclic adenosine monophosphate |
| Q30175300 | The HIV Nef protein alters Ca(2+) signaling in myelomonocytic cells through SH3-mediated protein-protein interactions |
| Q26749030 | The Use of 1α,25-Dihydroxyvitamin D₃ as an Anticancer Agent |
| Q26852652 | The characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseases |
| Q38066201 | The plasticity and potential of leukemia cell lines to differentiate into dendritic cells |
| Q39796064 | The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts. |
| Q73804092 | The role of vitamin D derivatives and retinoids in the differentiation of human leukaemia cells |
| Q36941178 | The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites |
| Q37138638 | The vitamin D receptor in cancer |
| Q70279949 | Topical administration of 1,25-dihydroxyvitamin D3 for psoriasis: report of five cases |
| Q41697668 | Topoisomerase Inhibitors Have Potent Differentiation-inducing Activity for Human and Mouse Myeloid Leukemia Cells |
| Q70145653 | Transcriptional regulation of the transferrin receptor in differentiating HL-60 leukemic cells |
| Q42775574 | Transcriptomes reflect the phenotypes of undifferentiated, granulocyte and macrophage forms of HL-60/S4 cells |
| Q68883768 | Transforming growth factor-beta 1 modulates the effect of 1 alpha, 25-dihydroxyvitamin D3 on leukemic cells |
| Q42653581 | Treatment of psoriasis vulgaris by oral administration of 1 alpha-hydroxyvitamin D3--open-design study |
| Q41809956 | Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon |
| Q34589176 | Tumor necrosis factor inhibits MYC expression in HL-60 cells at the level of mRNA transcription |
| Q28571840 | Two distinct mechanisms for loss of thioredoxin-binding protein-2 in oxidative stress-induced renal carcinogenesis |
| Q24294482 | Up- or downregulation of tescalcin in HL-60 cells is associated with their differentiation to either granulocytic or macrophage-like lineage |
| Q43118976 | Update of preclinical and human studies of calcium and colon cancer prevention. |
| Q45071253 | Vitamin D Receptor Signaling and Cancer |
| Q36509508 | Vitamin D and cancer: clinical aspects |
| Q37507817 | Vitamin D metabolites change the phenotype of monoblastic U937 cells |
| Q39840021 | Vitamin D, phagocyte differentiation and immune function |
| Q24545558 | Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes |
| Q33759350 | Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy |
| Q58757535 | Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications |
| Q69155815 | [1 alpha 25-dihydroxyvitamin D3 (calcitriol) and malignant hemopathies. Decreased serum levels in acute leukemia: preliminary results] |
Search more.